Skip to main content
main content, press tab to continue
Survey Report

What’s driving global medical trend

2022 Global Medical Trends Survey Report

November 15, 2021

The 2022 survey tracks medical costs from a global network of 209 insurers in 61 countries. Explore key findings and trends at a glance.
Benefits Administration and Outsourcing Solutions|Health and Benefits
N/A

The cost drivers remain largely unchanged from prior years, from an insurer viewpoint:

  • The overuse of care due to medical practitioners recommending too many services or overprescribing continues to be the leading driver of medical costs. The percentage of insurers citing this factor as a leading cost driver held steady at 64%, down slightly from 65% last year.
  • Similarly, the overuse of care by insured members continues to be the second most important driver of medical costs, with 59% of insurers indicating that this is a significant cost driver, up four percentage points from last year.
  • Understandably the percentage of employers indicating that the underuse or lack of preventive services is a significant cost driver rose from 34% last year to 38% in this year’s survey. This can be largely attributed to delay or avoidance of medical care during the pandemic.

Top conditions globally

By cost

Cancer, cardiovascular and musculoskeletal are the top three conditions by cost as was the case in the prior year (Figure 1); however, the biggest surprise was the percentage of insurers citing musculoskeletal as a top condition by cost, which jumped from 41% last year to 52% in this year’s survey. This can be largely attributed to remote workers’ sedentary lifestyle, which can increase the risk of musculoskeletal injuries.

It is expected that cancer, cardiovascular and musculoskeletal will remain the top three fastest-growing conditions by cost over the next 18 months.

fullscreenEnlarge this table
Figure 1. Top five conditions currently by cost
Global Latin America Asia Pacific Europe Middle East and Africa
1 Cancer (neoplasms) Cancer (neoplasms) Cancer (neoplasms) Musculoskeletal and connective tissue Circulatory system (cardiovascular)
2 Circulatory system (cardiovascular) Circulatory system (cardiovascular) Circulatory system (cardiovascular) Cancer (neoplasms) Cancer (neoplasms)
3 Musculoskeletal and connective tissue COVID-19 Musculoskeletal and connective tissue Circulatory system (cardiovascular) Diabetes, endocrine, nutritional and metabolic diseases
4 Mental and behavioral disorders Diabetes, endocrine, nutritional and metabolic diseases Digestive system (gastrointestinal) Mental and behavioral disorders COVID-19
5 Diabetes, endocrine, nutritional and metabolic diseases Musculoskeletal and connective tissue Injury and other consequences of external cause Injury and other consequences of external cause Digestive system (gastrointestinal)


By incidence

Musculoskeletal, cardiovascular and respiratory are the top three conditions by incidence (Figure 2). Cancer dropped from number one to number five this year, likely due to delayed treatment during the pandemic. This year saw musculoskeletal move into the top spot, whereas last year it was number five. The prevalence of respiratory conditions can in part be attributed to COVID-19. Looking ahead to the next 18 months, insurers expect mental and behavioral disorders, cancer and musculoskeletal to be the fastest-growing conditions in terms of incidence.



fullscreenEnlarge this table
Figure 2. Top five conditions currently by incidence
Global Latin America Asia Pacific Europe Middle East and Africa
1 Musculoskeletal and connective tissue Diabetes, endocrine, nutritional and metabolic diseases Digestive system (gastrointestinal) Musculoskeletal and connective tissue Respiratory
2 Circulatory system (cardiovascular) Digestive system (gastrointestinal) Circulatory system (cardiovascular) Circulatory system (cardiovascular) Diabetes, endocrine, nutritional and metabolic diseases
3 Respiratory Circulatory system (cardiovascular) Musculoskeletal and connective tissue Cancer (neoplasms) COVID-19
4 Digestive system (gastrointestinal) COVID-19 Respiratory Mental and behavioral disorders Musculoskeletal and connective tissue
5 Cancer (neoplasms) Cancer (neoplasms) Cancer (neoplasms) Digestive system (gastrointestinal) Mental and behavioral disorders


Regional perspectives

Cancer continues to be the leading condition by cost in Latin America and Asia Pacific. In Europe, musculoskeletal is the leading condition by cost; in the Middle East and Africa cardiovascular is the costliest condition.

Cardiovascular is the second leading condition by cost in Latin America and Asia Pacific. Cancer is the second costliest condition in Europe and in the Middle East and Africa.

When it comes to incidence of claims, there is even more variation by region. In Latin America, respondents rated diabetes as the leading condition by incidence, whereas in Asia Pacific, gastrointestinal is the top condition. In Europe, musculoskeletal is the leading condition by incidence; in Middle East and Africa, respiratory is in the top spot.


Over half of insurers cited musculoskeletal as a top condition by cost.

Next section: Managing medical trend

Download

Title File Type File Size
2022 Global Medical Trends Survey Report PDF 15.1 MB
Contact us